-+ 0.00%
-+ 0.00%
-+ 0.00%

STRUCTURE THERAPEUTICS INC - ALENIGLIPRON TO ADVANCE TO PHASE 3 CLINICAL DEVELOPMENT

Reuters·12/08/2025 13:00:03

Please log in to view news